Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.72K Buy
1,503
+530
+54% +$1.66K ﹤0.01% 2302
2026
Q1
$2.84K Hold
973
– – ﹤0.01% 2332
2025
Q4
$2.4K Buy
+973
New +$2.32K ﹤0.01% 2319
2020
Q3
– Sell
-22,759
Closed -$60K – 359
2020
Q2
$60K Buy
+22,759
New +$53.7K 0.01% 351
2014
Q4
– Sell
-2,000
Closed -$13K – 302
2014
Q3
$13K Hold
2,000
– – ﹤0.01% 996
2014
Q2
$14K Hold
2,000
– – ﹤0.01% 957
2014
Q1
$15K Hold
2,000
– – 0.01% 821
2013
Q4
$15K Buy
+2,000
New +$14.6K 0.01% 795

Other funds holding ABEV

Private Trust Company's ABEV Position: Q2 2026 in Review

Private Trust Company increased its Ambev (ABEV) stake by 54% in Q2 2026, buying an estimated $1.66K and bringing the position to 1,503 shares worth $4.72K. The position accounts for ﹤0.01% of the portfolio, ranked #2302.

Private Trust Company first reported a position in ABEV in Q4 2013 and has held it in 8 quarters since. The position peaked at $60K in Q2 2020. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Private Trust Company held 1,503 shares of Ambev worth $4.72K as of Q2 2026.
  • Private Trust Company bought 530 Ambev shares in Q2 2026, an estimated $1.66K.
  • Ambev made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2302 holding.
  • Private Trust Company first reported a position in Ambev in Q4 2013 and has held it in 8 quarters since.
  • Private Trust Company's Ambev position peaked at $60K in Q2 2020.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.